Nitric oxide and cancer therapy: the emperor has NO clothes

JR Hickok, DD Thomas - Current pharmaceutical design, 2010 - ingentaconnect.com
The role of nitric oxide (NO•) as a mediator of cancer phenotype has led researchers to
investigate strategies for manipulating in vivo production and exogenous delivery of this …

Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities

S Mocellin, V Bronte, D Nitti - Medicinal research reviews, 2007 - Wiley Online Library
Nitric oxide (NO) is a pleiotropic molecule critical to a number of physiological and
pathological processes. The last decade has witnessed major advances in dissecting NO …

The regulation of nitric oxide in tumor progression and therapy

Y Hu, J Xiang, L Su, X Tang - Journal of International …, 2020 - journals.sagepub.com
Nitric oxide (NO) is a ubiquitous gas with free radical groups that is soluble in water, and
which is involved in numerous physiological functions including inflammatory and immune …

Nitric oxide—a novel therapeutic for cancer

JA Coulter, HO McCarthy, J Xiang, W Roedl, E Wagner… - Nitric oxide, 2008 - Elsevier
Much research over the past two decades has focussed on understanding the complex
interactions of nitric oxide (NO) in both physiological and pathological processes. As with …

Targeting nitric oxide for cancer therapy

D Hirst, T Robson - Journal of Pharmacy and Pharmacology, 2007 - Wiley Online Library
A blueprint for the ideal anticancer molecule would include most of the properties of nitric
oxide (NO•), but the ability to exploit these characteristics in a therapeutic setting requires a …

Nitric oxide: cancer target or anticancer agent?

S Mocellin - Current cancer drug targets, 2009 - ingentaconnect.com
Despite the improved understanding of nitric oxide (NO) biology and the large amount of
preclinical experiments testing its role in cancer development and progression, it is still …

Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies

S Singh, AK Gupta - Cancer chemotherapy and pharmacology, 2011 - Springer
Purpose The diatomic radical nitric oxide (NO) has been the cause of intense debate with
implication in carcinogenesis, tumour progression, invasion, angiogenesis and modulation …

Nitric oxide and cancer: When to give and when to take away?

KM Miranda, LA Ridnour, CL McGinity… - Inorganic …, 2021 - ACS Publications
The mechanistic roles of nitric oxide (NO) during cancer progression have been important
considerations since its discovery as an endogenously generated free radical. Nonetheless …

Nitric oxide: the forgotten child of tumor metabolism

BS Rizi, A Achreja, D Nagrath - Trends in cancer, 2017 - cell.com
Nitric oxide (NO) is a signaling molecule with pleiotropic physiological roles in normal cells
and pathophysiological roles in cancer. NO synthetase expression and NO synthesis are …

Nitric oxide in cancer therapeutics: interaction with cytotoxic chemotherapy

D Hirst, T Robson - Current pharmaceutical design, 2010 - ingentaconnect.com
Nitric oxide is a key second messenger in most tissues, where it is generated at low
concentrations, predominantly by the catalytic action of two constitutively expressed isoforms …